{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-119799","form_type":"8-K","ticker":"CHD","cik":"0000313927","company_name":"CHURCH & DWIGHT CO INC /DE/","filed_at":"2024-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.683306+00:00","generated_at":"2026-05-30T07:06:32.955274+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Church & Dwight Q3 adj. EPS $0.79 beats outlook; vitamin impairment drives reported loss","bullets":["Q3 net sales $1,510.6M (+3.8%); organic sales +4.3% led by volume (+3.1%).","Adjusted EPS $0.79 vs. outlook of $0.67; reported loss per share -$0.31 from $357M vitamin impairment charge.","Domestic organic +3.3%, International +8.1%, SPD +7.5%; marketing spend +80bps to 12.3% of sales.","Full-year adj. EPS growth reaffirmed at +8%; gross margin expansion raised to +110bps; cash from ops ~$1.1B.","Q4 outlook: organic sales +2-3%, adj. EPS $0.76 (+17% YoY); cautious on US consumer."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-119799","json":"https://secwatch.observer/filing/0000950170-24-119799.json","markdown":"https://secwatch.observer/filing/0000950170-24-119799.md","text":"https://secwatch.observer/filing/0000950170-24-119799.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/313927/000095017024119799/0000950170-24-119799-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/313927/000095017024119799/chd-20241101.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T07:06:32.955274+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}